Page last updated: 2024-11-02

oxaprozin and Respiratory Tract Infections

oxaprozin has been researched along with Respiratory Tract Infections in 1 studies

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsumoto, K1
Fujimori, I1
Tsubura, E1
Sakuma, A1
Hayashi, M1
Kudo, K1
Kimura, H1
Kono, M1
Sekita, T1
Takeda, Y1

Trials

1 trial available for oxaprozin and Respiratory Tract Infections

ArticleYear
[Clinical evaluation of oxaprozin in the treatment of acute upper respiratory tract inflammations--a double-blind comparative study using ibuprofen as the control drug].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1984, Volume: 58, Issue:7

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Clinical Trials as Topic; Double-Blind Method; Female;

1984